Iosune Baraibar
Overview
Explore the profile of Iosune Baraibar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
612
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ros J, Ucha J, Garcia-Galea E, Gomez P, Martini G, Balconi F, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766040
Background: For patients with refractory metastatic colorectal cancer (mCRC), trifluridine/tipiracil (FTD-TPI) has been associated with a significant improvement in overall survival (OS). However, data are lacking regarding the activity of...
2.
Garcia-Alfonso P, Jimenez-Fonseca P, Soto-Alsar J, Baraibar I, Santos C, La Casta A, et al.
Oncologist
. 2024 Nov;
PMID: 39550209
Introduction: The initial SARS-CoV-2 pandemic wave in Spain in 2020 precipitated significant paradigm shifts in gastrointestinal oncology patient management. This study captures the "Zeitgeist" of this period by analyzing adaptive...
3.
Genova C, Marconi S, Chiorino G, Guana F, Ostano P, Santamaria S, et al.
Clin Exp Med
. 2024 Aug;
24(1):182.
PMID: 39105937
Immune checkpoint inhibitors (ICIs) have revolutionized the management of advanced non-small cell lung cancer (NSCLC), although patient survival is still unsatisfactory. Accurate predictive markers capable of personalizing the treatment of...
4.
Salva de Torres C, Baraibar I, Saoudi Gonzalez N, Ros J, Salva F, Rodriguez-Castells M, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000083
The treatment of unresectable metastatic colorectal cancer has evolved over the last two decades, as knowledge of cancer biology has broadened and new targets have emerged. 'The Hallmarks of Cancer'...
5.
Salva F, Saoudi N, Rodriguez M, Baraibar I, Ros J, Garcia A, et al.
Clin Colorectal Cancer
. 2024 Jul;
23(3):207-214.
PMID: 38981843
Colorectal cancer (CRC) is a complex and genetically heterogeneous disease presenting a specific metastatic pattern, with the liver being the most common site of metastasis. Around 20%-25% of patients with...
6.
Cabrero-de Las Heras S, Hernandez-Yague X, Gonzalez A, Losa F, Soler G, Buges C, et al.
Biomed Pharmacother
. 2024 Jun;
176:116857.
PMID: 38850664
Metastatic colorectal cancer (mCRC) currently lacks reliable biomarkers for precision medicine, particularly for chemotherapy-based treatments. This study examines the behavior of 11 CXC chemokines in the blood of 104 mCRC...
7.
Saoudi Gonzalez N, Marchese P, Baraibar I, Ros J, Salva F, Rodriguez M, et al.
Expert Opin Investig Drugs
. 2024 May;
33(6):613-625.
PMID: 38775361
Introduction: The global prevalence of colorectal cancer highlights the need to enhance treatment strategies for improved patient outcomes. The pivotal role of epidermal growth factor receptor (EGFR) signaling in regulating...
8.
Ros J, Vaghi C, Baraibar I, Saoudi Gonzalez N, Rodriguez-Castells M, Garcia A, et al.
Int J Mol Sci
. 2024 Mar;
25(6).
PMID: 38542278
Kirsten rat sarcoma virus oncogene homolog () is the most frequently mutated oncogene in human cancer. In colorectal cancer (CRC), mutations are present in more than 50% of cases, and...
9.
Saoudi Gonzalez N, Ros J, Baraibar I, Salva F, Rodriguez-Castells M, Alcaraz A, et al.
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254903
Cetuximab, a chimeric IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR), has revolutionized personalized treatment of metastatic colorectal cancer (mCRC) patients. This review highlights the mechanism of action,...
10.
Rodriguez Castells M, Baraibar I, Ros J, Saoudi N, Salva F, Garcia A, et al.
Front Oncol
. 2023 Nov;
13:1272561.
PMID: 37909013
The journey of metastatic colorectal cancer patients is complex and challenging, requiring coordination and collaboration between multiple healthcare providers. Understanding patients' needs, fears, feelings, concerns, and behaviors is essential for...